Incidence and severity of COVID-19 in patients with autoimmune blistering skin diseases: A nationwide study.

Joly, Pascal

Joly, Pascal.

Joly P; Department of Dermatology, Rouen University Hospital, Centre de référence des maladies bulleuses autoimmunes and INSERM U1234, Normandie University, Rouen, France. Electronic address: Pascal.Joly@chu-rouen.fr.

J Am Acad Dermatol ; 86(2): 494-497, 2022 02.

Article in English | MEDLINE | ID: covidwho-1594521

Subject(s)

Autoimmune Diseases; COVID-19; Skin Diseases, Vesiculobullous; Autoimmune Diseases/epidemiology; Blister/epidemiology; COVID-19/epidemiology; Humans; Incidence; Skin Diseases, Vesiculobullous/epidemiology

Keywords

COVID-19; autoimmune bullous skin diseases; mortality; rituximab

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Autoimmune Diseases / Skin Diseases, Vesiculobullous / COVID-19 Type of study: Observational study / Prognostic study Limits: Humans Language: English Journal: J Am Acad Dermatol Year: 2022 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google